Cargando…
Antiviral drugs specific for coronaviruses in preclinical development
Coronaviruses are positive stranded RNA viruses that cause respiratory, enteric and central nervous system diseases in many species, including humans. Until recently, the relatively low burden of disease in humans caused by few of these viruses impeded the development of coronavirus specific therape...
Autores principales: | Adedeji, Adeyemi O, Sarafianos, Stefan G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195804/ https://www.ncbi.nlm.nih.gov/pubmed/24997250 http://dx.doi.org/10.1016/j.coviro.2014.06.002 |
Ejemplares similares
-
Biochemical Characterization of Middle East Respiratory Syndrome Coronavirus Helicase
por: Adedeji, Adeyemi O., et al.
Publicado: (2016) -
Drug Interactions in Lenacapavir-Based Long-Acting Antiviral Combinations
por: Cilento, Maria E., et al.
Publicado: (2022) -
Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design
por: Xu, Xiang, et al.
Publicado: (2003) -
Mechanism of Nucleic Acid Unwinding by SARS-CoV Helicase
por: Adedeji, Adeyemi O., et al.
Publicado: (2012) -
Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020)